Log in
Enquire now
Gemelli Biotech

Gemelli Biotech

Novel diagnostics and therapeutics for the human microbiome, gut gas profile

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
CEO
Matt Mitcho
Matt Mitcho
Legal Name
Gemelli Biotech Corp.
Company Operating Status
Active
Competitors
Immunome
Immunome
Halo Labs
Halo Labs
BioFluidica
BioFluidica
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...-biotech
Email Address
hello@gemellibiotech.com
Facebook URL
@gemellibiotech
Founded Date
July 18, 2018
Founder
Matt Mitcho
Matt Mitcho
Ali Rezaie
Ali Rezaie
Ruchi Mathur
Ruchi Mathur
Industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Investors
CerraCap Ventures
CerraCap Ventures
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Cedars-Sinai Accelerator
Cedars-Sinai Accelerator
Blue Ox Healthcare Partners
Blue Ox Healthcare Partners
Carolina Angel Network
Carolina Angel Network
Latest Funding Round Date
June 22, 2022
Latest Funding Round Amount (USD)
19,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/gemellibiotech
Location
Raleigh, North Carolina
Raleigh, North Carolina
Number of Employees
22
Number of Employees (Ranges)
11 – 50
Pitchbook URL
pitchbook.com/profiles...268431-40
Total Funding Amount (USD)
19,000,000
Twitter URL
@gemellibiotech
Official Website
gemellibiotech.com

Find more companies like Gemelli Biotech

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.